MedTrace Logo

Brief Cognitive Behavioral Therapy for Reducing Suicidal Ideation in Economically Distressed Migrants

NCT07111377 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-08-08

No results posted yet for this study

Summary

This randomized controlled trial assessed the efficacy of an 8-session, culturally adapted Brief Cognitive Behavioral Therapy (Brief CBT) compared to Treatment as Usual (TAU) in reducing suicidal ideation among economically distressed migrant workers in the United Arab Emirates. Participants (N=120) were randomized to receive Brief CBT or TAU. Outcomes were assessed at baseline, 4-weeks, 8-weeks, and 3-month follow-up.

Conditions

Interventions

BEHAVIORAL

Brief Cognitive Behavioral Therapy

Participants received an 8-session culturally adapted Brief Cognitive Behavioral Therapy intervention targeting suicidal ideation, psychological distress, and financial stress. Therapy included crisis stabilization, cognitive restructuring of maladaptive thoughts related to economic hardship, behavioral activation, problem-solving skills for financial and psychosocial stressors, and emotion-regulation training. It concluded with relapse prevention planning and connection to supportive community resources. Sessions were delivered weekly, either individually (60 minutes) or in groups (90 minutes), based on participant preference.

Sponsors & Collaborators

  • Bath Spa University Academic Centre RAK

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-10
Primary Completion
2024-10-15
Completion
2024-11-25

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07111377 on ClinicalTrials.gov